Top Story

Akynzeo approved for CINV

HemOnc Today, November 25, 2014

Read the Perspective from Christine A. Zawistowski, MD

The FDA approved Akynzeo for the treatment of nausea and vomiting in patients with cancer who are undergoing chemotherapy.

Akynzeo — a fixed combination capsule composed of palonosetron (Aloxi; Eisai, Helsinn Healthcare) and netupitant (Eisai, Helsinn Healthcare) — is designed to treat nausea and vomiting during the acute and delayed phases after chemotherapy (CINV).

Meeting News CoveragePerspective

Hospice symptom management system benefited patients, caregivers

October 23, 2014
A telephone-based symptom monitoring and coaching system improved patient symptoms and their caregiver’s well-being during hospice care, according to study results…
Meeting News CoveragePerspective

Many cancer survivors face financial, work-related hardships

October 22, 2014
More than one-quarter of cancer survivors faced at least one financial difficulty, and more than one-third of survivors who worked had to modify their work plans due to…
Meeting News CoveragePerspective

Oncology, palliative care partnership reduced patients’ lengths of stay, readmission rates

October 22, 2014
A “co-rounding” partnership between medical oncologists and palliative care specialists on an inpatient oncology ward was associated with shorter hospital lengths of…
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
FDA approvalsPerspective

Akynzeo approved for CINV

HemOnc Today, November 25, 2014
The FDA approved Akynzeo for the treatment of nausea and vomiting in patients with cancer who are undergoing chemotherapy.Akynzeo — a fixed…
Meeting News CoveragePerspective

Hospice symptom management system benefited patients, caregivers

October 23, 2014
A telephone-based symptom monitoring and coaching system improved patient symptoms and their caregiver’s well-being during hospice care, according to…
Meeting News CoveragePerspective

Many cancer survivors face financial, work-related hardships

October 22, 2014
More than one-quarter of cancer survivors faced at least one financial difficulty, and more than one-third of survivors who worked had to modify…
Meeting News CoveragePerspective

Oncology, palliative care partnership reduced patients’ lengths of stay, readmission rates

October 22, 2014
A “co-rounding” partnership between medical oncologists and palliative care specialists on an inpatient oncology ward was associated with shorter…
Meeting News CoveragePerspective

Patients often change lifestyle, medical care due to cancer costs

October 21, 2014
The financial burden of cancer care often prompted insured patients to alter their lifestyle and their medical care strategies, according to survey…
In the Journals

Aprepitant regimen reduced CINV in post-transplant myeloma

October 21, 2014
The addition of the NK-1 antagonist aprepitant to granisetron and dexamethasone reduced nausea and vomiting among patients with myeloma who underwent…
Meeting News CoveragePerspective

Parental status influenced cancer care decisions

October 15, 2014
Patients with advanced cancer who were parents often based their decisions about aggressive cancer treatment and hospice care on the fact they had…

Just-in-Time management principles helped reduce patient wait time

October 1, 2014
Applying processes used in manufacturing to streamline patient flow can successfully reduce patient wait time and increase the confidence of…
Meeting News CoveragePerspective

Addition of chemotherapy to radiation failed to improve outcomes in esophageal cancer

September 18, 2014
The addition of chemotherapy to radiation therapy increased gastrointestinal toxicity but did not confer significant improvement in dysphagia or…
Robert A. Olson, MD, MSc Meeting News CoveragePerspective

Single-fraction radiation effective for bone metastases

September 17, 2014
Patients with bone metastases who underwent single-fraction palliative radiation therapy reported similar improvements in pain, function and distress…
More Headlines »